Coloplast (UK) Today

0QBO Stock   886.80  11.35  1.30%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Coloplast is selling for under 886.80 as of the 25th of November 2024; that is 1.30 percent up since the beginning of the trading day. The stock's lowest day price was 886.8. Coloplast has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Coloplast AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of February 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain
Commercial & Professional Services
Classification
Industrials
Coloplast is entity of United Kingdom. It is traded as Stock on LSE exchange. More on Coloplast AS

Moving against Coloplast Stock

  0.45NBS Nationwide Building Earnings Call This WeekPairCorr
  0.450K1R Viridian TherapeuticsPairCorr

Coloplast Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Coloplast's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Coloplast or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President CEOKristian Villumsen
Business ConcentrationEnvironmental & Facilities Services, Commercial & Professional Services, Industrials, Industrials, Commercial Services & Supplies, Commercial & Professional Services, Industrials (View all Sectors)
Coloplast AS (0QBO) is traded on London Exchange in UK and employs 16,639 people. Coloplast is listed under Environmental & Facilities Services category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 190.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast's market, we take the total number of its shares issued and multiply it by Coloplast's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Coloplast AS operates under Commercial Services & Supplies sector and is part of Industrials industry. Coloplast generates positive cash flow from operations, but has no cash available
Check Coloplast Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Coloplast AS is USD190.16 Billion. Coloplast AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Coloplast Ownership Details

Coloplast AS Risk Profiles

Although Coloplast's alpha and beta are two of the key measurements used to evaluate Coloplast's performance over the market, the standard measures of volatility play an important role as well.

Coloplast Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Coloplast without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Coloplast Corporate Management

Elected by the shareholders, the Coloplast's board of directors comprises two types of representatives: Coloplast inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Coloplast. The board's role is to monitor Coloplast's management team and ensure that shareholders' interests are well served. Coloplast's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Coloplast's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ellen BjurgertVice RelationsProfile
Allan RasmussenExecutive OperationsProfile
Alain MorvanSenior EuropeProfile
Nicolai AndersenExecutive InnovationProfile

Additional Tools for Coloplast Stock Analysis

When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.